Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine
Jason S. Richardson, Michel K. Yao, Kaylie N. Tran et al. · 2009
Read Enhanced Protection against Ebola Virus Mediated by an Improved Adenovirus-Based Vaccine by Jason S. Richardson, Michel K. Yao, Kaylie N. Tran et al. (2009) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0005308.txt.
Description
Ebola virus spreads by direct contact with body fluids and can kill up to ninety percent of those infected. A vaccine based on a disabled adenovirus was already in early human testing. Richardson and colleagues tested an improved version in PLOS ONE in 2009.
The improved adenovirus-based vaccine gave enhanced protection against Ebola in their tests. Better protection from a vaccine platform already known to be safe is valuable progress. Outbreak response needs vaccines that work fast and strongly, and this work moves that goal closer. A strong vaccine for this virus must work in the field, where cold chains fail and care is far off. So each gain in strength gives outbreak teams a tool they can trust more.
Catalog record
| CREATOR | Jason S. Richardson, Michel K. Yao, Kaylie N. Tran et al. |
|---|---|
| YEAR | 2009 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 38 KB |
| LICENSE | Creative Commons Attribution License |
| RIGHTS | CC BY |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0005308